Patents by Inventor Stephen Crooks

Stephen Crooks has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

Intermediates for imidazonaphthyridines

Publication number: 20080091010

Abstract: Imidazonaphthyridine and tetrahydroimidazonaphthyridine compounds induce the biosynthesis of cytokines such as interferon and tumor necrosis factor. The compounds exhibit antiviral and antitumor properties. Methods of preparing the compounds and intermediates useful in the preparation of the compounds are disclosed.

Type: Application

Filed: December 6, 2007

Publication date: April 17, 2008

Applicant: Graceway Pharmaceuticals, LLC

Inventors: John Gerster, Kyle Lindstrom, Stephen Crooks, Philip Heppner, Gregory Marszalek, Peter Maye, Bryon Merrill, John Mickelson, Michael Rice
INTERMEDIATES FOR IMIDAZONAPHTHYRIDINES

Publication number: 20060128674

Abstract: Imidazonaphthyridine and tetrahydroimidazonaphthyridine compounds induce the biosynthesis of cytokines such as interferon and tumor necrosis factor. The compounds exhibit antiviral and antitumor properties. Methods of preparing the compounds and intermediates useful in the preparation of the compounds are disclosed.

Type: Application

Filed: February 13, 2006

Publication date: June 15, 2006

Inventors: John Gerster, Kyle Lindstrom, Stephen Crooks, Philip Heppner, Gregory Marszalek, Peter Maye, Bryon Merrill, John Mickelson, Michael Rice
METHOD OF USING SULFONAMIDE SUBSTITUTED IMIDAZOQUINOLINES

Publication number: 20060106052

Abstract: Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain sulfonamide or sulfonamide functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.

Type: Application

Filed: January 25, 2006

Publication date: May 18, 2006

Inventors: Stephen Crooks, Bryon Merrill
IMIDAZONAPHTHYRIDINES

Publication number: 20050288320

Abstract: Imidazonaphthyridine and tetrahydroimidazonaphthyridine compounds induce the biosynthesis of cytokines such as interferon and tumor necrosis factor. The compounds exhibit antiviral and antitumor properties. Methods of preparing the compounds and intermediates useful in the preparation of the compounds are also disclosed.

Type: Application

Filed: July 25, 2005

Publication date: December 29, 2005

Inventors: John Gerster, Kyle Lindstrom, Stephen Crooks, Philip Heppner, Gregory Marszalek, Peter Maye, Bryon Merrill, John Mickelson, Michael Rice
Sulfonamido ether substituted imidazoquinolines

Publication number: 20050148620

Abstract: Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain ether and sulfonamide or sulfamide functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.

Type: Application

Filed: February 28, 2005

Publication date: July 7, 2005

Inventors: Stephen Crooks, George Griesgraber, Philip Heppner, Bryon Merrill, Ralph Roberts, Ai-Ping Wei
Sulfonamido ether substituted imidazoquinolines

Publication number: 20050148619

Abstract: Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain ether and sulfonamide or sulfamide functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.

Type: Application

Filed: February 28, 2005

Publication date: July 7, 2005

Inventors: Stephen Crooks, George Griesgraber, Philip Heppner, Bryon Merrill, Ralph Roberts, Ai-Ping Wei
Amido ether substituted imidazoquinolines

Publication number: 20050143413

Abstract: Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain ether and amide functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.

Type: Application

Filed: February 28, 2005

Publication date: June 30, 2005

Inventors: Stephen Crooks, George Griesgraber, Philip Heppner, Bryon Merrill
Urea substituted imidazoquinolines

Publication number: 20050131009

Abstract: Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain urea, thiourea, acylurea, or sulfonylurea functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.

Type: Application

Filed: January 20, 2005

Publication date: June 16, 2005

Inventors: Stephen Crooks, George Griesgraber, Kyle Lindstrom, Bryon Merrill, Michael Rice
Imidazonaphthyridines

Publication number: 20050107421

Abstract: Imidazonaphthyridine and tetrahydroimidazonaphthyridine compounds induce the biosynthesis of cytokines such as interferon and tumor necrosis factor. The compounds exhibit antiviral and antitumor properties. Methods of preparing the compounds and intermediates useful in the preparation of the compounds are also disclosed.

Type: Application

Filed: December 3, 2004

Publication date: May 19, 2005

Inventors: John Gerster, Kyle Lindstrom, Stephen Crooks, Philip Heppner, Gregory Marszalck, Peter Maye, Bryon Merrill, John Mickelson, Michael Rice